| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Investigative Ophthalmology & Visual Science, Vol 38, 593-599, Copyright © 1997 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
SD Trocme, CK Hallberg, KS Gill, GJ Gleich, SK Tyring and MM Brysk
Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, School of Medicine, Galveston, USA.
PURPOSE: There is mounting evidence that eosinophil granule proteins may cause tissue injury during allergic inflammation of the eye. Therefore, the authors investigated the in vitro effects of human eosinophil major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophil-derived neurotoxin (EDN) on cultured human corneal epithelial cell viability and morphology. METHODS: Confluent primary human corneal epithelial cell cultures were exposed to each of the four human eosinophil cationic granule proteins at concentrations ranging from 0 to 100 micrograms/ml (0, 12.5, 25, 50, and 100 micrograms/ml) for up to 48 hours in serum- free media. Morphologic changes were assessed by light microscopy at 1, 6, 24, and 48 hours; cell viability was measured using the MTT cell viability assay at 24 hours. RESULTS: Cells treated with MBP and ECP induced a dose-dependent gradual increase in morphologic changes; in contrast, EPO and EDN induced minimal changes in cell morphology. At 24 hours, both MBP and ECP induced statistically significant (P < 0.05) decreases in cell viability at a concentration of 100 micrograms/ml; EPO induced a significant (P < 0.05) decrease in cell viability at all concentrations tested, and EDN showed no significant reduction of cell viability at any of the concentrations tested. CONCLUSIONS: The current study suggests that the human eosinophil granule proteins MBP and ECP affect human corneal epithelial cell viability and morphology in vitro, whereas the protein EPO affects cell viability only. EDN had no significant effect on cell viability or morphology. Hence, MBP, ECP, and EPO perturb the corneal epithelium differentially and may contribute to keratopathy associated with severe ocular allergy.
This article has been cited by other articles:
|
|
 |
|
  A. Fukushima, T. Yamaguchi, W. Ishida, K. Fukata, H. Yagita, and H. Ueno Roles of OX40 in the Development of Murine Experimental Allergic Conjunctivitis: Exacerbation and Attenuation by Stimulation and Blocking of OX40 Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Okada, K. Fukagawa, Y. Takano, M. Dogru, K. Tsubota, H. Fujishima, K. Matsumoto, T. Nakajima, and H. Saito The Implications of the Upregulation of ICAM-1/VCAM-1 Expression of Corneal Fibroblasts on the Pathogenesis of Allergic Keratopathy Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4512 - 4518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fukushima, T. Yamaguchi, W. Ishida, K. Fukata, R. S. Mittler, H. Yagita, and H. Ueno Engagement of 4-1BB Inhibits the Development of Experimental Allergic Conjunctivitis in Mice J. Immunol., October 15, 2005; 175(8): 4897 - 4903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Takano, K Fukagawa, M Dogru, N Asano-Kato, K Tsubota, and H Fujishima Inflammatory cells in brush cytology samples correlate with the severity of corneal lesions in atopic keratoconjunctivitis Br. J. Ophthalmol., December 1, 2004; 88(12): 1504 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Leonardi, P. Brun, G. Abatangelo, M. Plebani, and A. G. Secchi Tear Levels and Activity of Matrix Metalloproteinase (MMP)-1 and MMP-9 in Vernal Keratoconjunctivitis Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3052 - 3058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Berger, N. M. Blackwell, J. H. Lass, E. Diaconu, and E. Pearlman IL-4 and IL-13 Regulation of ICAM-1 Expression and Eosinophil Recruitment in Onchocerca volvulus Keratitis Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2992 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fukagawa, N. Okada, H. Fujishima, T. Nakajima, K. Tsubota, Y. Takano, H. Kawasaki, H. Saito, and K. Hirai CC-Chemokine Receptor 3: A Possible Target in Treatment of Allergy-Related Corneal Ulcer Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 58 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Abu El-Asrar, I. Van Aelst, S. Al-Mansouri, L. Missotten, G. Opdenakker, and K. Geboes Gelatinase B in Vernal Keratoconjunctivitis Arch Ophthalmol, October 1, 2001; 119(10): 1505 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Hall, E. Diaconu, and E. Pearlman A Dominant Role for Fc{{gamma}} Receptors in Antibody-Dependent Corneal Inflammation J. Immunol., July 15, 2001; 167(2): 919 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M A. El-Asrar, S. Struyf, S. A Al-Kharashi, L. Missotten, J. Van Damme, and K. Geboes Chemokines in the limbal form of vernal keratoconjunctivitis Br. J. Ophthalmol., December 1, 2000; 84(12): 1360 - 1366. [Abstract] [Full Text]
|
|
|
|
|
|
N. Kumagai, K. Fukuda, Y. Ishimura, and T. Nishida Synergistic Induction of Eotaxin Expression in Human Keratocytes by TNF-{alpha} and IL-4 or IL-13 Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1448 - 1453. [Abstract] [Full Text]
|
|
|
|
|
|
L. R. Hall, J. H. Lass, E. Diaconu, E. R. Strine, and E. Pearlman An Essential Role for Antibody in Neutrophil and Eosinophil Recruitment to the Cornea: B Cell-Deficient ({micro}MT) Mice Fail to Develop Th2-Dependent, Helminth-Mediated Keratitis J. Immunol., November 1, 1999; 163(9): 4970 - 4975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takano, K. Fukagawa, S. Shimmura, K. Tsubota, Y. Oguchi, and H. Saito IL-4 regulates chemokine production induced by TNF-alpha in keratocytes and corneal epithelial cells Br. J. Ophthalmol., September 1, 1999; 83(9): 1074 - 1076. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. R. Hall and E. Pearlman Pathogenesis of Onchocercal Keratitis (River Blindness) Clin. Microbiol. Rev., July 1, 1999; 12(3): 445 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yokoi, N. Yokoi, and S. Kinoshita Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis Br. J. Ophthalmol., July 1, 1998; 82(7): 797 - 800. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
